A synthetic pharma quantitative primary market research worked example: from decision to results

The short version

A quantitative primary market research (PMR) study becomes useful when the team can connect five things: a specific commercial decision, a defined audience, a fit-for-purpose questionnaire, controlled fieldwork, and an interpretation plan that is honest about what the data can and cannot support.

The example below follows a fictional oncology HCP concept-preference exercise called Project Cedar. Each step carries meaningful, repetitive work that a research team has to manage before the study can move forward. The example shows how keeping that work connected and reviewable gives the team the context to discuss the next decision.

1. Start with the decision

Which of three blinded product-profile directions deserves another round of message and concept development with oncology HCPs in the United States and Germany?

A survey is not automatically the right answer to every commercial uncertainty. AAPOR's survey-research guidance recommends starting with an unambiguous objective, checking whether existing evidence already answers the question, and considering whether another method is more appropriate.

2. Define the audience

• Medical oncologists and hematology-oncology physicians who treat adults with metastatic solid tumors.
• United States and Germany.
• 60 planned completes per market, 120 total.
• An 80% medical-oncology / 20% hematology-oncology mix in each market.

Sample quality is broader than a respondent count. The ESOMAR/GRBN online sample-quality guidance covers participant validation, fraud prevention, engagement, exclusions, sampling, and transparency about how the sample was obtained. NquiRx helps keep study context, fieldwork decisions, and review steps connected so those choices can be addressed alongside the rest of the study.

3. Design the questionnaire

The three profiles are labeled A, B, and C. Their administration and operational descriptions are invented for the exercise, and efficacy and safety details are intentionally withheld. The questionnaire asks respondents to review the profiles, choose which they would discuss further with an appropriate patient, explain the choice, and identify the trade-off they would want to understand next.

Profile A Blinded stimulus Reviewed attributes

Profile B Blinded stimulus Reviewed attributes

Profile C Blinded stimulus Reviewed attributes

Compare consistently → Capture choice and rationale → Define the next question

4. Ensure quality

The first review round catches ordinary but consequential issues:

1. The decision statement could be read as a prescribing forecast.
2. Profile attributes could be mistaken for claims about a real medicine.
3. Exposure-order randomization needs a structured setting.
4. A preference question should not be labeled as intent to prescribe.
5. Optional open text can create privacy, translation, coding, or safety-routing work.
6. Every result table must carry its illustrative status into the deck and downloads.

NquiRx automatically inspects a draft for study-quality advisories, and Nquirer can prepare a suggested Draft Review revision or reclarification. Once the owner reviews and applies a change, the workflow can regenerate the questionnaire draft for the next review round. Teams can collaborate in-platform or through a reviewed NquiRx Word export/import round; imported feedback remains reviewable and is not silently accepted.

NquiRx's workflow connects the Project Cedar brief, questionnaire review, fieldwork follow-ups, and reporting outputs in one study record. Nquirer can organize the brief, surface missing assumptions, turn a reviewer comment into a proposed revision, draft a vendor follow-up, and organize analysis inputs while the team owns the objective, audience, stimulus, sample, approvals, and final interpretation.

5. Review the results

Profile A leads in both markets, with 52% of the total selection versus 31% for Profile C and 18% for Profile B. That is the immediate readout and a clear prompt for the next round: which profile attributes or messages should be tested further?

The open-end responses help explain the pattern. NquiRx helps aggregate insights from open end answers:

access convenience confidence evidence monitoring visit burden patients nurses center clinic oncology follow-up

A team could use those themes to prioritize message refinement, a qualitative follow-up, or a revised question in the next round.

Summary

Key decision points

1. Decision and audience fit. Confirm what decision the research can inform and whom it needs to reach.
2. Stimulus and wording. Review profile language, disclosures, translations, and exclusions.
3. Questionnaire quality. Resolve review findings before accepting the next draft.
4. Programming and launch QA. Verify routing, scales, exposure order, required responses, links, and respondent-facing behavior.
5. Results interpretation. Carry sample and data-quality context into the analysis and sign off on the narrative.